Depending on the cell line, certain growth factor treatments such as EGF (Epidermal growth factor) or IGF1 (Insulin-like growth factor 1), or targeted kinase inhibitor treatments, can enhance castration resistant growth or treat castration resistant cancer through modulating signal transduction pathways. Here, EGF is linked to cancer.